AtriCure, Inc. (ATRC) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
"main_header": {
"sid": 1150701,
"name": "AtriCure, Inc.",
"stock_name": "AtriCure, Inc.",
"full_name": "AtriCure, Inc.",
"name_url": "stocks-analysis/atricure-inc",
"exchange": 210,
"exchangecode": "NAS",
"country_id": 2,
"currency": "USD",
"cmp": "39.25",
"chg": 3.94,
"chgp": "11.16%",
"dir": 1,
"prev_price": "35.31",
"mcapval": "1,789.25",
"mcap": "Small Cap",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 2325,
"indexname": "S&P 500",
"isin": "US04963C2098",
"curr_date": "Dec 04",
"curr_time": "",
"bse_nse_vol": "2.01 M",
"exc_status": "Active",
"traded_date": "Dec 04, 2025",
"traded_date_str": "2025 12 04",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-registerF-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/atricure-inc-1150701-210&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "Is AtriCure, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-atricure-inc-technically-bullish-or-bearish-3673575",
"imagepath": "",
"date": "2025-11-05 11:20:00",
"description": "As of 31 October 2025, the technical trend for AtriCure, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish, indicating mixed signals. The daily moving averages are mildly bullish, suggesting some positive momentum. However, the weekly Bollinger Bands are bearish, contrasting with the monthly Bollinger Bands which are mildly bullish. The KST shows a bullish monthly trend but is mildly bearish on the weekly timeframe. Overall, the technical stance is mildly bullish, but the strength is tempered by bearish indicators on the weekly charts.\n\nIn terms of performance, AtriCure has underperformed compared to the S&P 500 across multiple periods, notably with a year-to-date return of 7.17% versus the S&P 500's 16.30%, and a 1-year return of -2.27% compared to 19.89% for the benchmark...."
},
{
"title": "Is AtriCure, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-atricure-inc-technically-bullish-or-bearish-3670764",
"imagepath": "",
"date": "2025-11-04 11:31:28",
"description": "As of 31 October 2025, the technical trend for AtriCure, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a mildly bullish signal from the daily moving averages and a monthly bullish signal from the KST. However, the weekly MACD and Bollinger Bands indicate a mildly bearish and bearish outlook, respectively. \n\nIn terms of performance, AtriCure has underperformed the S&P 500 across multiple periods, with a year-to-date return of 11.35% compared to the S&P 500's 16.30%, and a one-year return of 1.55% versus 19.89% for the benchmark. Overall, the mixed signals suggest caution despite the mildly bullish trend...."
},
{
"title": "Is AtriCure, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-atricure-inc-technically-bullish-or-bearish-3666356",
"imagepath": "",
"date": "2025-11-03 11:30:32",
"description": "As of 31 October 2025, the technical trend for AtriCure, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The daily moving averages also reflect a mildly bullish stance. However, the weekly OBV is mildly bearish, which suggests some selling pressure. The Bollinger Bands are sideways on the weekly timeframe but mildly bullish on the monthly, indicating potential for upward movement.\n\nIn terms of performance, AtriCure has underperformed the S&P 500 over the 1-year and 3-year periods, returning 4.13% compared to the S&P's 19.89% and -17.97% compared to the S&P's 76.66%, respectively. Overall, the current technical stance is mildly bullish, but the strength is tempered by mixed signals from the OBV and the lack of strong RSI signals...."
},
{
"title": "Is AtriCure, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-atricure-inc-technically-bullish-or-bearish-3664473",
"imagepath": "",
"date": "2025-11-02 11:16:28",
"description": "As of 31 October 2025, the technical trend for AtriCure, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating some positive momentum. The daily moving averages also reflect a mildly bullish stance. However, the weekly OBV is mildly bearish, suggesting some selling pressure. The Bollinger Bands are sideways on the weekly timeframe but mildly bullish on the monthly, indicating potential for upward movement.\n\nIn terms of performance, AtriCure's returns have lagged behind the S&P 500 across multiple periods, with a year-to-date return of 13.06% compared to the S&P's 16.30%, and a one-year return of 4.13% versus 19.89%. Overall, the current technical stance is mildly bullish, but with caution due to mixed signals from various indicators...."
},
{
"title": "Is AtriCure, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-atricure-inc-technically-bullish-or-bearish-3547134",
"imagepath": "",
"date": "2025-09-20 19:47:53",
"description": "As of 12 September 2025, the technical trend for AtriCure, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed indicators influencing this position. The weekly MACD and Bollinger Bands are bullish, while the Dow Theory and OBV are mildly bearish. Daily moving averages remain bullish, but the RSI shows no signal on both weekly and monthly time frames. \n\nIn terms of performance, AtriCure has outperformed the S&P 500 year-to-date and over the past year, with returns of 19.96% and 30.98% respectively, compared to 12.22% and 17.14% for the index. However, longer-term returns over 3, 5, and 10 years are significantly negative compared to the S&P 500...."
},
{
"title": "Is AtriCure, Inc. overvalued or undervalued?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-atricure-inc-overvalued-or-undervalued-3543565",
"imagepath": "",
"date": "2025-09-20 18:22:51",
"description": "As of 1 November 2022, AtriCure, Inc. moved from a fair to a risky valuation grade, indicating a shift towards a more negative outlook. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 3.80 and an EV to Sales ratio of 3.53, which suggest that investors are paying a premium relative to its book value and sales. Additionally, the negative ROCE of -5.50% and ROE of -5.76% further highlight the company's struggles in generating returns.\n\nIn comparison to its peers, AtriCure's valuation ratios are concerning; for instance, Sanmina Corp. has a P/E ratio of 39.80, while AtriCure's valuation is classified as risky with a P/E ratio of -92.43. Other peers like iRhythm Technologies and Glaukos Corp. also reflect risky valuations, but AtriCure's metrics stand out for their extreme negativity. Despite a strong YTD return of 19.96%, AtriCure has underperformed the..."
},
{
"title": "AtriCure, Inc. Experiences Evaluation Revision Amidst Mixed Market Signals and Performance Trends",
"link": "https://www.marketsmojo.com/news/stocks-in-action/atricure-inc-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-mixed-indicators-3522754",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/9/AtriCureInc_technicaldot_3522754.png",
"date": "2025-09-16 18:39:53",
"description": "AtriCure, Inc. has recently revised its evaluation amid changing market conditions. The stock is priced at $34.63, with a notable annual return of 22.76%, surpassing the S&P 500. Technical indicators show mixed signals, suggesting a need for close monitoring of the company's performance in the current market landscape."
}
],
"total": 12,
"sid": "1150701",
"stock_news_url": "https://www.marketsmojo.com/news/atricure-inc-1150701"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}

News and Views

Is AtriCure, Inc. technically bullish or bearish?

2025-11-05 11:20:00

As of 31 October 2025, the technical trend for AtriCure, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish, indicating mixed signals. The daily moving averages are mildly bullish, suggesting some positive momentum. However, the weekly Bollinger Bands are bearish, contrasting with the monthly Bollinger Bands which are mildly bullish. The KST shows a bullish monthly trend but is mildly bearish on the weekly timeframe. Overall, the technical stance is mildly bullish, but the strength is tempered by bearish indicators on the weekly charts. In terms of performance, AtriCure has underperformed compared to the S&P 500 across multiple periods, notably with a year-to-date return of 7.17% versus the S&P 500's 16.30%, and a 1-year return of -2.27% compared to 19.89% for the benchmark....

Is AtriCure, Inc. technically bullish or bearish?

2025-11-04 11:31:28

As of 31 October 2025, the technical trend for AtriCure, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a mildly bullish signal from the daily moving averages and a monthly bullish signal from the KST. However, the weekly MACD and Bollinger Bands indicate a mildly bearish and bearish outlook, respectively. In terms of performance, AtriCure has underperformed the S&P 500 across multiple periods, with a year-to-date return of 11.35% compared to the S&P 500's 16.30%, and a one-year return of 1.55% versus 19.89% for the benchmark. Overall, the mixed signals suggest caution despite the mildly bullish trend....

Is AtriCure, Inc. technically bullish or bearish?

2025-11-03 11:30:32

As of 31 October 2025, the technical trend for AtriCure, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive momentum. The daily moving averages also reflect a mildly bullish stance. However, the weekly OBV is mildly bearish, which suggests some selling pressure. The Bollinger Bands are sideways on the weekly timeframe but mildly bullish on the monthly, indicating potential for upward movement. In terms of performance, AtriCure has underperformed the S&P 500 over the 1-year and 3-year periods, returning 4.13% compared to the S&P's 19.89% and -17.97% compared to the S&P's 76.66%, respectively. Overall, the current technical stance is mildly bullish, but the strength is tempered by mixed signals from the OBV and the lack of strong RSI signals....

Is AtriCure, Inc. technically bullish or bearish?

2025-11-02 11:16:28

As of 31 October 2025, the technical trend for AtriCure, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating some positive momentum. The daily moving averages also reflect a mildly bullish stance. However, the weekly OBV is mildly bearish, suggesting some selling pressure. The Bollinger Bands are sideways on the weekly timeframe but mildly bullish on the monthly, indicating potential for upward movement. In terms of performance, AtriCure's returns have lagged behind the S&P 500 across multiple periods, with a year-to-date return of 13.06% compared to the S&P's 16.30%, and a one-year return of 4.13% versus 19.89%. Overall, the current technical stance is mildly bullish, but with caution due to mixed signals from various indicators....

Is AtriCure, Inc. technically bullish or bearish?

2025-09-20 19:47:53

As of 12 September 2025, the technical trend for AtriCure, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed indicators influencing this position. The weekly MACD and Bollinger Bands are bullish, while the Dow Theory and OBV are mildly bearish. Daily moving averages remain bullish, but the RSI shows no signal on both weekly and monthly time frames. In terms of performance, AtriCure has outperformed the S&P 500 year-to-date and over the past year, with returns of 19.96% and 30.98% respectively, compared to 12.22% and 17.14% for the index. However, longer-term returns over 3, 5, and 10 years are significantly negative compared to the S&P 500....

Is AtriCure, Inc. overvalued or undervalued?

2025-09-20 18:22:51

As of 1 November 2022, AtriCure, Inc. moved from a fair to a risky valuation grade, indicating a shift towards a more negative outlook. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 3.80 and an EV to Sales ratio of 3.53, which suggest that investors are paying a premium relative to its book value and sales. Additionally, the negative ROCE of -5.50% and ROE of -5.76% further highlight the company's struggles in generating returns. In comparison to its peers, AtriCure's valuation ratios are concerning; for instance, Sanmina Corp. has a P/E ratio of 39.80, while AtriCure's valuation is classified as risky with a P/E ratio of -92.43. Other peers like iRhythm Technologies and Glaukos Corp. also reflect risky valuations, but AtriCure's metrics stand out for their extreme negativity. Despite a strong YTD return of 19.96%, AtriCure has underperformed the...

AtriCure, Inc. Experiences Evaluation Revision Amidst Mixed Market Signals and Performance Trends

2025-09-16 18:39:53

AtriCure, Inc. has recently revised its evaluation amid changing market conditions. The stock is priced at $34.63, with a notable annual return of 22.76%, surpassing the S&P 500. Technical indicators show mixed signals, suggesting a need for close monitoring of the company's performance in the current market landscape.

View All News